Efficacy of a novel chewable tablet (Credelio Quattro™) containing lotilaner, moxidectin, praziquantel, and pyrantel for the treatment and control of hookworm infections in dogs
Credelio Quattro, a novel oral chewable tablet administered at the minimum effective dosages of 20 mg/kg lotilaner, 0.02 mg/kg moxidectin, 5.0 mg/kg praziquantel, and 5.0 mg/kg pyrantel (as pamoate salt), was safe and effective for the treatment and control of L<sub>4</sub>, immature adult, and adult stages of A. caninum and adult U. stenocephala in dogs.
Authors
- Lisa Young (ORCID: https://orcid.org/0000-0001-8804-4152)
- Katrin Deuster
- Luther van der Mescht (ORCID: https://orcid.org/0000-0001-8813-9549)
- Abdelmoneim Mansour
- Scott Wiseman (ORCID: https://orcid.org/0000-0002-0269-6684)
- Craig R. Reinemeyer (ORCID: https://orcid.org/0000-0002-7641-3042)
- Imad Bouzaidi Cheikhi
- Samuel Charles
- Xinshuo Wang
Institutions
- University of the Free State (ZA)
- TRS Technologies (United States) (US)
- East Tennessee Clinical Research (US)
- Elanco (United States) (US)
- Clinvet (ZA)
- Université Mohammed VI Polytechnique (MA)
Publication Details
- Journal
- Parasites & Vectors
- Published
- 2025-04-02
- DOI
- https://doi.org/10.1186/s13071-025-06757-4
- Citations
- 2
- Primary Topic
- Parasites and Host Interactions
- Type
- article
- Field-Weighted Citation Impact
- 4.10
Funders
- Elanco Animal Health